Lewis, Charles P. http://orcid.org/0000-0001-8791-657X
Nakonezny, Paul A.
Blacker, Caren J.
Vande Voort, Jennifer L.
Port, John D. http://orcid.org/0000-0002-4237-7776
Worrell, Gregory A.
Jo, Hang Joon
Daskalakis, Zafiris J.
Croarkin, Paul E. http://orcid.org/0000-0001-6843-6503
Article History
Received: 24 August 2017
Revised: 5 January 2018
Accepted: 26 February 2018
First Online: 14 March 2018
Competing interests
: CPL receives research support from the Mayo Clinic Foundation Departmental Small Grant Program and is a site investigator for a multicenter study funded by Neuronetics, Inc. CJB receives research support from the Mayo Clinic Foundation Departmental Small Grant Program. JLVV receives equipment in-kind support from Assurex Health, Inc. for an investigator-initiated study and is a site investigator for a multicenter study funded by Neuronetics, Inc. GAW has received research support from Medtronic, Inc., Neuralynx, Inc., and Neuropace, Inc. ZJD has received research and equipment in-kind support for an investigator-initiated study from Brainsway Ltd.; he also has served on the advisory board for F. Hoffmann-La Roche Ltd. and Merck & Co., Inc. and has received speaker support from Eli Lilly and Co. PEC has received research grant support from Pfizer, Inc., NIMH (K23 MH100266), the Brain and Behavior Research Foundation, and the Mayo Clinic Foundation. He has served as a site subprincipal or principal investigator (without additional compensation) for Eli Lilly and Co., Forest Laboratories, Inc., Merck & Co., Inc., and Pfizer, Inc.; has received equipment support from Neuronetics, Inc.; and receives supplies and genotyping services from Assurex Health, Inc. for an investigator-initiated study. He is a site primary investigator for a multicenter study funded by Neuronetics, Inc. The other authors declare no competing interests.